Acadia Pharmaceuticals Stock Price on October 25, 2024
| ACAD Stock | USD 16.32 0.03 0.18% |
Below is the normalized historical share price chart for ACADIA Pharmaceuticals extending back to May 27, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ACADIA Pharmaceuticals stands at 16.32, as last reported on the 1st of December, with the highest price reaching 16.41 and the lowest price hitting 16.16 during the day.
If you're considering investing in ACADIA Stock, it is important to understand the factors that can impact its price. At this point, ACADIA Pharmaceuticals is very steady. ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of 0.0091, which signifies that the company had a 0.0091% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for ACADIA Pharmaceuticals, which you can use to evaluate the volatility of the entity. Please confirm ACADIA Pharmaceuticals' coefficient of variation of 2703.15, and Market Risk Adjusted Performance of 0.0557 to double-check if the risk estimate we provide is consistent with the expected return of 0.0202%.
At present, ACADIA Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3 B, whereas Capital Stock is forecasted to decline to about 17.1 K. . At present, ACADIA Pharmaceuticals' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 322.45, whereas Price Earnings Ratio is projected to grow to (79.51). ACADIA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of May 2004 | 200 Day MA 17.0544 | 50 Day MA 15.615 | Beta 0.379 |
ACADIA |
Sharpe Ratio = 0.0091
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACAD |
Estimated Market Risk
| 2.22 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ACADIA Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ACADIA Pharmaceuticals by adding ACADIA Pharmaceuticals to a well-diversified portfolio.
Price Book 4.7048 | Enterprise Value Ebitda 17.6613 | Price Sales 2.9223 | Shares Float 109 M | Wall Street Target Price 25.1053 |
Related Headline
Viking Therapeutics Headline on 25th of October 2024
Filed transaction by Viking Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
ACADIA Pharmaceuticals Valuation on October 25, 2024
It is possible to determine the worth of ACADIA Pharmaceuticals on a given historical date. On October 25, 2024 ACADIA was worth 14.52 at the beginning of the trading date compared to the closed value of 14.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ACADIA Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find ACADIA Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACADIA Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ACADIA Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 14.29 | 14.50 | 14.26 | 14.48 | 783,374 | |
10/25/2024 | 14.52 | 14.60 | 14.34 | 14.34 | 583,196 |
| 14.44 | 14.81 | 14.31 | 14.74 | 819,649 |
| Backtest ACADIA Pharmaceuticals | | | ACADIA Pharmaceuticals History | | | ACADIA Pharmaceuticals Valuation | Previous | Next |
ACADIA Pharmaceuticals Trading Date Momentum on October 25, 2024
| On October 28 2024 ACADIA Pharmaceuticals was traded for 14.74 at the closing time. The top price for the day was 14.81 and the lowest listed price was 14.31 . The trading volume for the day was 819.6 K. The trading history from October 28, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 2.79% . The overall trading delta against the current closing price is 2.72% . |
ACADIA Pharmaceuticals Fundamentals Correlations and Trends
By evaluating ACADIA Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ACADIA Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ACADIA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ACADIA Pharmaceuticals Stock history
ACADIA Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ACADIA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ACADIA Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ACADIA Pharmaceuticals stock prices may prove useful in developing a viable investing in ACADIA Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 163.8 M | 172 M | |
| Net Loss | -194.4 M | -204.1 M |
ACADIA Pharmaceuticals Quarterly Net Working Capital |
|
ACADIA Pharmaceuticals Stock Technical Analysis
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ACADIA Pharmaceuticals Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
ACADIA Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ACADIA Pharmaceuticals December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how ACADIA Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ACADIA Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying ACADIA Pharmaceuticals stock market strength indicators, traders can identify ACADIA Pharmaceuticals entry and exit signals to maximize returns
ACADIA Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ACADIA Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of ACADIA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ACADIA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0349 | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0457 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |